Literature DB >> 12916947

Preparation of solid dispersions of nonsteroidal anti-inflammatory drugs with acrylic polymers and studies on mechanisms of drug-polymer interactions.

Rosario Pignatello1, Marinella Ferro, Giovanni Puglisi.   

Abstract

This work studied the mechanisms of interaction between Eudragit RS100 (RS) and RL100 (RL) polymers with 3 nonsteroidal anti-inflammatory drugs: diflunisal (DIF), flurbiprofen (FLU), and piroxicam (PIR). Solid dispersions of polymers and drugs at different weight ratios were prepared by coevaporation of their ethanol solutions. The resulting coevaporates were characterized in the solid state (Fourier-transformed infrared spectroscopy (FT-IR) IR, differential scanning calorimetry, powder-x-ray diffractometry) as well as by studying the in vitro drug release in a gastroenteric environment. Absorption tests from drug solutions to the solid polymers were also performed to better explain the mechanism of interactions between them. The preparative conditions did not induce changes in the crystalline state of the drugs (amorphization or polymorphic change). Drugs strongly interacted with the ammonium groups present in polymers, giving an electrostatic interaction that reinforced the mere physical dispersion of drug molecules within polymer networks. Such interactions are related to the chemical structure of the drugs and to their dissociated or undissociated state. The dispersion of drugs in the polymer matrices strongly influenced their dissolution rate, which appeared slower and more gradual than those of the pure drugs, when polymer ratios were increased. RL coevaporates usually displayed higher dissolution rates. The kinetic evaluation of the dissolution profile, however, suggested that both the drug solubility in the external medium and its diffusion capacity within the polymer network are involved. In the sorption experiments, RL showed a greater adsorptive capacity than RS, in relation to the greater number of quaternary ammonium functions, which behave as activity sites for the electrostatic interactions. In the presence of Tris-HCl buffer (pH 7.4), drug adsorption was reduced, as a consequence of the competition of the chloride ions with drug anions for the polymer binding sites. In general, DIF and FLU displayed a similar interaction with RS and RL active sites; PIR's was different. The different molecular structures of these agents can justify such findings. The presence of a carboxyl group (instead of another dissociable acidic moiety, like the hydroxy-enolic one in the PIR molecule) could help explain the strong interaction with RS and RL polymers' quaternary ammonium centers. Preliminary studies like ours are important in helping develop better forecasting and increasing the understanding of the incorporation/release behavior of drugs from particulate delivery systems that can be made from these polymers.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12916947      PMCID: PMC2750312          DOI: 10.1208/pt030210

Source DB:  PubMed          Journal:  AAPS PharmSciTech        ISSN: 1530-9932            Impact factor:   3.246


  9 in total

1.  In vitro release kinetics of Tolmetin from tabletted Eudragit microparticles.

Authors:  R Pignatello; P Consoli; G Puglisi
Journal:  J Microencapsul       Date:  2000 May-Jun       Impact factor: 3.142

2.  Preparation and dissolution pattern of Eudragit RS microcapsules containing ketoprofen.

Authors:  M Kawata; M Nakamura; S Goto; T Aoyama
Journal:  Chem Pharm Bull (Tokyo)       Date:  1986-06       Impact factor: 1.645

3.  Physical and chemical factors influencing the release of drugs from acrylic resin films.

Authors:  M R Jenquin; S M Liebowitz; R E Sarabia; J W McGinity
Journal:  J Pharm Sci       Date:  1990-09       Impact factor: 3.534

4.  Preparation, characterisation and photosensitivity studies of solid dispersions of diflunisal and Eudragit RS100 and RL100.

Authors:  R Pignatello; M Ferro; G De Guidi; G Salemi; M A Vandelli; S Guccione; M Geppi; C Forte; G Puglisi
Journal:  Int J Pharm       Date:  2001-05-07       Impact factor: 5.875

5.  Microencapsulation of paracetamol using polyacrylate resins (Eudragit Retard), kinetics of drug release and evaluation of kinetic model.

Authors:  S Benita; A Hoffman; M Donbrow
Journal:  J Pharm Pharmacol       Date:  1985-06       Impact factor: 3.765

6.  Flurbiprofen-loaded acrylate polymer nanosuspensions for ophthalmic application.

Authors:  R Pignatello; C Bucolo; G Spedalieri; A Maltese; G Puglisi
Journal:  Biomaterials       Date:  2002-08       Impact factor: 12.479

7.  Physical characterization and dissolution properties of ibuprofen: Eudragit coprecipitates.

Authors:  M S Kislalioglu; M A Khan; C Blount; R W Goettsch; S Bolton
Journal:  J Pharm Sci       Date:  1991-08       Impact factor: 3.534

8.  Eudragit RS and RL (acrylic resins) microcapsules as pH insensitive and sustained release preparations of ketoprofen.

Authors:  S Goto; M Kawata; M Nakamura; K Maekawa; T Aoyama
Journal:  J Microencapsul       Date:  1986 Oct-Dec       Impact factor: 3.142

9.  Eudragit RS100 nanosuspensions for the ophthalmic controlled delivery of ibuprofen.

Authors:  Rosario Pignatello; Claudio Bucolo; Piera Ferrara; Adriana Maltese; Antonina Puleo; Giovanni Puglisi
Journal:  Eur J Pharm Sci       Date:  2002-07       Impact factor: 4.384

  9 in total
  12 in total

1.  Polymeric drug nanoparticles prepared by an aerosol flow reactor method.

Authors:  Hannele Eerikäinen; Esko I Kauppinen; Jarno Kansikas
Journal:  Pharm Res       Date:  2004-01       Impact factor: 4.200

2.  Molecular properties of ibuprofen and its solid dispersions with Eudragit RL100 studied by solid-state nuclear magnetic resonance.

Authors:  Marco Geppi; Salvatore Guccione; Giulia Mollica; Rosario Pignatello; Carlo A Veracini
Journal:  Pharm Res       Date:  2005-08-24       Impact factor: 4.200

3.  Nanoparticles containing ketoprofen and acrylic polymers prepared by an aerosol flow reactor method.

Authors:  Hannele Eerikäinen; Leena Peltonen; Janne Raula; Jouni Hirvonen; Esko I Kauppinen
Journal:  AAPS PharmSciTech       Date:  2004-09-23       Impact factor: 3.246

4.  Molecular properties of flurbiprofen and its solid dispersions with Eudragit RL100 studied by high- and low-resolution solid-state nuclear magnetic resonance.

Authors:  Giulia Mollica; Marco Geppi; Rosario Pignatello; Carlo A Veracini
Journal:  Pharm Res       Date:  2006-08-09       Impact factor: 4.200

5.  Design and optimization of diclofenac sodium controlled release solid dispersions by response surface methodology.

Authors:  H N Shivakumar; B G Desai; G Deshmukh
Journal:  Indian J Pharm Sci       Date:  2008-01       Impact factor: 0.975

6.  Flurbiprofen release from Eudragit RS and RL aqueous nanosuspensions: a kinetic study by DSC and dialysis experiments.

Authors:  Francesco Castelli; Chiara Messina; Maria Grazia Sarpietro; Rosario Pignatello; Giovanni Puglisi
Journal:  AAPS PharmSciTech       Date:  2002       Impact factor: 3.246

7.  3-aminopropyl functionalized magnesium phyllosilicate as an organoclay based drug carrier for improving the bioavailability of flurbiprofen.

Authors:  Liang Yang; Soo-Kyung Choi; Hyun-Jae Shin; Hyo-Kyung Han
Journal:  Int J Nanomedicine       Date:  2013-10-30

8.  Nanoencapsulation of the sasanquasaponin from Camellia oleifera, its photo responsiveness and neuroprotective effects.

Authors:  Yong Ye; Haiting Xing; Yue Li
Journal:  Int J Nanomedicine       Date:  2014-09-19

9.  Upconversion nanoparticles conjugated with curcumin as a photosensitizer to inhibit methicillin-resistant Staphylococcus aureus in lung under near infrared light.

Authors:  Yong Ye; Yue Li; Fei Fang
Journal:  Int J Nanomedicine       Date:  2014-11-06

10.  Unique growth pattern of human mammary epithelial cells induced by polymeric nanoparticles.

Authors:  Rajaa Hussien; Bertrand H Rihn; Housam Eidi; Carole Ronzani; Olivier Joubert; Luc Ferrari; Oscar Vazquez; Daniela Kaufer; George A Brooks
Journal:  Physiol Rep       Date:  2013-09-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.